Entity

pembrolizumab

pharmaceutical drug

Express your sentiment! Sign in!

Entity sentiment

1

Sep 8, 2024, 4:22 PM

WCLC 2024: Ivonescimab Outperforms Pembrolizumab in NSCLC Trial

Aug 8, 2024, 10:46 AM

Merck Stops Lung Cancer Drug Trial

pembrolizumab Merck & Co.

You've reached the end